Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a multi-center, open-label extension (OLE) study in patients with plaque psoriasis who have completed their participation in a previous plaque psoriasis study of ESK-001.
Epistemonikos ID: f49fc02f88f1ca3ca03356a28da06237b700bd13
First added on: Feb 19, 2024